E-DRUG: UNITAID RFP: hepatitis C medicines and diagnostics in HIV/HCV co-infection
----------------------------------------------------------------------------
UNITAID Invitation to bid - ITB 2013.06 "Services to provide an overview of
issues, challenges and opportunities with regard to hepatitis C medicines
and diagnostics in the context of HIV/HCV co-infection"
UNITAID is a global health initiative, established to provide sustainable,
predictable and additional funding to significantly impact on market
dynamics to reduce prices and increase the availability and supply of high
quality medicines, diagnostics and related commodities for the treatment of
HIV/AIDS, malaria and tuberculosis, primarily for populations in low-income
and lower-middle income countries.
UNITAID provides funding support to programmatic partners across three
disease areas (HIV/AIDS, tuberculosis and malaria) to address gaps in the
provision of quality medicines, diagnostics and other health commodities
through market-based approaches and interventions. We have a need for
suitably qualified bidders for a UNITAID project to provide "an overview of
issues, challenges and opportunities with regard to hepatitis C medicines
and diagnostics in the context of HIV/HCV co-infection".
A description of the requirements is provided in the following website:
http://bit.ly/WTunam. If you are interested in being considered for this
work, please respond no later than 22 February 2013, COB, to
laryeal@who.int<mailto:laryeal@who.int>.
Deadline date: 22 February 2013 at 17:00
Link to the ITB website/documents: http://bit.ly/WTunam
Link to UNITAID Website: http://www.unitaid.eu/
regards
Fabienne MAERTENS
Assistant (Team) - Market Dynamics
UNITAID
Geneva
Switzerland
Tel +41 22 791 1546
maertensf@unitaid.who.int
www.unitaid.eu